| scholarly article | Q13442814 |
| systematic review | Q1504425 |
| review article | Q7318358 |
| P50 | author | Timothy J Wilt | Q107974776 |
| P2093 | author name string | Roderick MacDonald | |
| Aasma Shaukat | |||
| Nancy Greer | |||
| Dimitri Drekonja | |||
| Indy Rutks | |||
| Selome Gezahegn | |||
| Jon Reich | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | feces | Q496 |
| Clostridium difficile | Q310543 | ||
| systematic review | Q1504425 | ||
| P304 | page(s) | 630-8 | |
| P577 | publication date | 2015-05-05 | |
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review | |
| P478 | volume | 162 |
| Q90092311 | "Implementation Is so Difficult": Survey of National Learning Health System Decision-makers Identifies Need For Implementation Information in Evidence Reviews |
| Q92999660 | Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders? |
| Q38766504 | Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome |
| Q35918566 | Breakthroughs in the treatment and prevention of Clostridium difficile infection |
| Q91995135 | Capsulized faecal microbiota transplantation ameliorates post-weaning diarrhoea by modulating the gut microbiota in piglets |
| Q38764998 | Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review. |
| Q40079041 | Changes in intestinal microbiota and their effects on allogeneic stem cell transplantation |
| Q64941132 | Characterization of Bacteriophages Infecting Clinical Isolates of Clostridium difficile. |
| Q37305507 | Clearance of Vancomycin-Resistant Enterococcus Concomitant With Administration of a Microbiota-Based Drug Targeted at Recurrent Clostridium difficile Infection |
| Q59132115 | Clinical Efficacy and Microbiome Changes Following Fecal Microbiota Transplantation in Children With Recurrent Clostridium Difficile Infection |
| Q33797074 | Clinical Genomics: Challenges and Opportunities |
| Q42365930 | Clinical Usefulness of Fecal Microbiota Transplantation |
| Q92967075 | Clostridium difficile Infection in Children |
| Q47142602 | Clostridium difficile infection in the elderly: an update on management |
| Q30239988 | Clostridium difficile infection: Updates in management |
| Q26750157 | Clostridium difficile infection: a review of current and emerging therapies |
| Q38914938 | Community dynamics drive punctuated engraftment of the fecal microbiome following transplantation using freeze-dried, encapsulated fecal microbiota. |
| Q49947171 | Comparison of Different Strategies for Providing Fecal Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile Infection in Two English Hospitals: A Review |
| Q42284238 | Complications, effectiveness, and long term follow-up of fecal microbiota transfer by nasoduodenal tube for treatment of recurrent Clostridium difficile infection |
| Q90500461 | Cost-effectiveness analysis of ribotype-guided fecal microbiota transplantation in Chinese patients with severe Clostridium difficile infection |
| Q48522020 | Diagnosis and Treatment of Clostridium difficile Infection (CDI). |
| Q64963415 | Digestive disorders and Intestinal microbiota. |
| Q92133701 | Durable Long-Term Bacterial Engraftment following Encapsulated Fecal Microbiota Transplantation To Treat Clostridium difficile Infection |
| Q36001267 | Dynamics of the fecal microbiome in patients with recurrent and nonrecurrent Clostridium difficile infection |
| Q55419358 | Early Results of Fecal Microbial Transplantation Protocol Implementation at a Community-based University Hospital. |
| Q40188521 | Editorial: Making Fecal Microbiota Transplantation Easier to Swallow: Freeze-Dried Preparation for Recurrent Clostridium difficile Infections |
| Q91868223 | Effect of Fermented Corn-Soybean Meal on Serum Immunity, the Expression of Genes Related to Gut Immunity, Gut Microbiota, and Bacterial Metabolites in Grower-Finisher Pigs |
| Q38770514 | European consensus conference on faecal microbiota transplantation in clinical practice. |
| Q90691813 | Faecal Transplantation, Pro- and Prebiotics in Parkinson's Disease; Hope or Hype? |
| Q98726065 | Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology |
| Q47112915 | Faecal microbiota transplantation in patients with Clostridium difficile and significant comorbidities as well as in patients with new indications: A case series |
| Q41147736 | Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate. |
| Q48007064 | Fecal Fixation: Fecal Microbiota Transplantation for Clostridium difficile Infection |
| Q54847969 | Fecal Micobiota Transplantation to Treat Sepsis of Unclear Etiology. |
| Q89885119 | Fecal Microbial Transplantation for the Treatment of Persistent Multidrug-Resistant Klebsiella pneumoniae Infection in a Critically Ill Patient |
| Q36102458 | Fecal Microbiota Therapy for Clostridium difficile Infection: A Health Technology Assessment |
| Q38740977 | Fecal Microbiota Transplant from a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial |
| Q36046935 | Fecal Microbiota Transplantation as a Novel Therapy for Ulcerative Colitis: A Systematic Review and Meta-Analysis |
| Q40587531 | Fecal Microbiota Transplantation for Inflammatory Bowel Disease |
| Q41987188 | Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency |
| Q39570973 | Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes |
| Q57292630 | Fecal Microbiota Transplantation for the Management of Clostridium difficile Infection |
| Q39435765 | Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease |
| Q26767161 | Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives |
| Q33717111 | Fecal Microbiota Transplantation: From Clostridium difficile to Inflammatory Bowel Disease |
| Q40813899 | Fecal Transplantation for Clostridium Difficile-"All Stool May Not Be Created Equal". |
| Q36241633 | Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease. |
| Q53720839 | Fecal microbial transplantation in a pediatric case of recurrent Clostridium difficile infection and specific antibody deficiency. |
| Q36793818 | Fecal microbiota transplant for Clostridium difficile infection in older adults. |
| Q39077926 | Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach |
| Q39395831 | Fecal microbiota transplantation for recurrent clostridium difficile infection in children. |
| Q33679180 | Fecal microbiota transplantation for refractory Crohn's disease |
| Q52691475 | Fecal microbiota transplantation reverses antibiotic and chemotherapy-induced gut dysbiosis in mice. |
| Q53740340 | Fecal microbiota transplantation via fluoroscopy-guided nasojejunal catheter placement: indications, technique, and the role of radiology. |
| Q39111479 | Geriatric Infectious Diseases: Current Concepts on Diagnosis and Management |
| Q38794312 | Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. |
| Q58756108 | Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection |
| Q26772308 | Gut microbiota in autism and mood disorders |
| Q90085905 | Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant |
| Q38969987 | Host response to Clostridium difficile infection: Diagnostics and detection |
| Q64096306 | Insights into the role of fecal microbiota transplantation for the treatment of inflammatory bowel disease |
| Q55264589 | Insights into the role of gut microbiota in obesity: pathogenesis, mechanisms, and therapeutic perspectives. |
| Q90347940 | International consensus conference on stool banking for faecal microbiota transplantation in clinical practice |
| Q64119534 | Intestinal Microbiota in Early Life and Its Implications on Childhood Health |
| Q98199249 | Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients |
| Q90634851 | Medical students' perception on fecal microbiota transplantation |
| Q38644054 | Microbial approaches for targeting antibiotic-resistant bacteria |
| Q26771287 | Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation |
| Q40834479 | Non-toxigenic Clostridium difficile to prevent recurrent C. difficile infection |
| Q35853017 | On the origin of species: Factors shaping the establishment of infant's gut microbiota. |
| Q40397168 | Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial |
| Q64985034 | Patient Knowledge and Attitudes About Fecal Microbiota Therapy for Clostridium difficile Infection. |
| Q91866917 | Potential relevance of pig gut content transplantation for production and research |
| Q57300359 | Protocol for Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis |
| Q47855608 | Recent Issues in Pediatric Clostridium difficile Infection |
| Q64124622 | Recurrence of Clostridium difficile infection in the Western Australian population |
| Q53828975 | Regional variability in fecal microbiota transplantation practices: a survey of the Southern Ontario Fecal Microbiota Transplantation Movement. |
| Q46284784 | Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management. |
| Q47599691 | Risk of Subsequent Sepsis within 90 Days of a Previous Hospital Stay by Type of Antibiotic Exposure |
| Q33466550 | Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study |
| Q52338338 | Scaling Safe Access to Fecal Microbiota Transplantation: Past, Present, and Future. |
| Q46299026 | Small molecule signaling, regulation, and potential applications in cellular therapeutics. |
| Q55437841 | Standardized Preparation for Fecal Microbiota Transplantation in Pigs. |
| Q40333936 | Successful Resolution of Recurrent Clostridium difficile Infection using Freeze-Dried, Encapsulated Fecal Microbiota; Pragmatic Cohort Study |
| Q35867850 | Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection |
| Q38679612 | Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection |
| Q37563802 | THE POWER OF POOP: FECAL MICROBIOTA TRANSPLANTATION FOR CLOSTRIDIUM DIFFICILE INFECTION. |
| Q90072442 | The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials |
| Q28274385 | The Gut as the Motor of Multiple Organ Dysfunction in Critical Illness |
| Q28072111 | The Hoops, Hopes, and Hypes of Human Microbiome Research |
| Q36295051 | The Human Microbiome and Understanding the 16S rRNA Gene in Translational Nursing Science |
| Q93016881 | The Role of the Canine Gut Microbiome and Metabolome in Health and Gastrointestinal Disease |
| Q52563104 | The hologenome concept of evolution after 10 years. |
| Q64903090 | The impact of intestinal microbiota on bio-medical research: definitions, techniques and physiology of a "new frontier". |
| Q92336435 | The success of fecal microbial transplantation in Clostridium difficile infection correlates with bacteriophage relative abundance in the donor: a retrospective cohort study |
| Q97568520 | The use of fecal microbiota transplant in sepsis |
| Q37564122 | Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders |
| Q38757930 | Therapies on the horizon for Clostridium difficile infections |
| Q53807330 | Treating Clostridium difficile infections: Should fecal microbiota transplantation be reclassified from investigational drug to human tissue? |
| Q36058419 | Understanding the mechanisms of faecal microbiota transplantation |
| Q93002732 | Updates in Treatment of Recurrent Clostridium difficile Infection |
| Q40264057 | Ursodeoxycholic Acid Inhibits Clostridium difficile Spore Germination and Vegetative Growth, and Prevents the Recurrence of Ileal Pouchitis Associated With the Infection. |
| Q38550160 | Use of intravenous immunoglobulin in severe Clostridium difficile-associated diarrhea |
| Q40181401 | Vancomycin Taper and Pulsed Regimen with careful Follow up for Patients with Recurrent Clostridium difficile Infection |
| Q40187487 | Vancomycin Taper and Risk of Failure of Fecal Microbiota Transplant in Patients With Recurrent Clostridium difficile Infection |
| Q42317942 | We are not alone: a case for the human microbiome in extra intestinal diseases. |
| Q58576978 | Zinc Deficiency and the Recurrence of Infection after Fecal Microbiota Transplant: A Retrospective Cohort Study |
| Q89427314 | [Intestinal microbiota] |
Search more.